Germline mutations in BAP1 are associated with tumor predisposition syndrome for mesotheliomas and melanocytic tumors [58,59], whereas deletions and point mutations have been identified in lung and breast cancers [57,60,61]. Here, BAP1 is linked to breast cancer.